NOVEMBER - 20205TECH OUTLOOKCXO INSIGHTSCXO INSIGHTSC O NT E NT SIN F CUSDe-risking the Preclinical Phase of Immunotherapy Drug DevelopmentRalph Gareus, Director Business Development, The Jackson Laboratory25RevolutionizingGenome Editing with CRISPRMark Behlke, CSO, Integrated DNA Technologies221928Pioneering Production and Delivery Solutions to Address the Complexities of Cell TherapyImpact of Advanced Manufacturing Technologies on the Pharmaceutical IndustryChristina Yi, Chief Operations Officer, DendreonAtul Dubey, Director, Pharmaceutical Continuous Manufacturing, US PharmacopeiaDanie du Plessis, Executive VP Medical Affairs, Kyowa Kirin [TYO: 4151]GENOMICSSOLUTION PROVIDERS - 2020TOP 10Pg 10 - 11Pg 16 - 24
< Page 4 | Page 6 >